News

Anthropic Launches Claude Science AI Workbench, Announces Plans to Develop Its Own Drugs

Anthropic has introduced Claude Science, a new AI workbench tailored for scientific research, at the "The Briefing: AI for Science" event. The platform aims to streamline scientific workflows by consolidating fragmented tools and datasets into a unified environment, while also generating figures and visualizations for researchers.

The company highlighted AI's potential to accelerate scientific discovery and healthcare intervention development, pointing to its existing roster of biotech and pharmaceutical customers already utilizing Claude. In a notable expansion of its business strategy, Anthropic also announced plans to develop drugs independently, moving beyond its role as an AI technology provider into direct therapeutic development.

Sources